Participants
Contact
The philologist Maria Blasco, who suffers from Friedreich’s ataxia, has published a book to raise funds for research into this rare and severe hereditary neurodegenerative disease. Written by 17 patients from eight countries, the proceeds from the sale of the novel are devoted to a gene therapy project led by Ernest Giralt, at IRB , and Javier Diaz Nido, at the Severo Ochoa Molecular Biology Centre in Madrid.
Read the news in Diario de notícias.
Related news
28 January 2014
International patient advocates partner to fund Spanish gene-therapy project to treat Friedreich's ataxia
14 November 2013
Patients and scientists join forces to tackle Friedreich’s Ataxia
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
